In-Vitro Maturation of Oocytes From Polycystic Ovarian Patients Undergoing IVF
In-Vitro Maturation of Oocytes From Polycystic Ovarian Patients Undergoing IVF
Retrieval of immature oocytes from women with polycystic ovaries, their in-vitro maturation,
 fertilization and embryo transfer can prevent hormonal treatment that can lead to ovarian
 hyperstimulation. In addition, it can decrease discomfort and side-effects of routine daily
 administration of hormones and it can be cost-effective. Thirty healthy women with Polycystic
 Ovarian Syndrome aged 20-35, with BMI 18-30 kg/msq will be included in the study. Their
 immature oocytes will be retrieved from small follicles without any hormonal treatment. The
 oocytes will be fertilized post in-vitro maturation. The developed embryros will be
 transferred to the patients as in a routine IVF cycle.
Inclusion Criteria:

 -  Healthy women diagnosed with Polycystic Ovarian Syndrome with BMI 18-30 kg/sqm, aged
 20-35

 Exclusion Criteria:

 -  Every one else